Prostate cancer is an important public health problem with over a quarter of a million new cases diagnosed worldwide in 1985 (Parkin et al. 1993). The incidence of the disease is increasing rapidly in most regions of the world (Boyle 1994; Alexander and Boyle, this volume) although the mortality rate has remained constant in generations of men born since the early years of this century (Boyle et al. 1994). The evidence that prostate cancer risk has important environmental determinants is compelling. Briefly, different populations around the world experience different levels of prostate cancer, and these levels change with time usually in an orderly and predictable manner: international variation in incidence is around two orders of magnitude (Boyle et al. 1994). However, when migration takes place, groups of migrants tend to acquire the prostate cancer pattern of their new home (Haenszel 1961). Furthermore, groups within a community whose life-style habits differentiate them from other members of the same community generally have notably different prostate cancer rates, for example, Seventh Day Adventists and Mormons (Zaridze and Boyle 1987).
KeywordsBenign Prostatic Hyperplasia Prostate Cancer Risk Male Breast Cancer Total Caloric Intake Benign Prostatic Hyperplasia Patient
Unable to display preview. Download preview PDF.
- Boyle P (1994) Prostate cancer 2000: evolution of an epidemic of unknown origin. In: Denis L (ed) Prostate cancer 2000. Springer, Berlin Heidelberg, New YorkGoogle Scholar
- Boyle P, Alexander FE (1994) Screening for prostate cancer: principles, methods and evaluation. Urology (in press)Google Scholar
- Boyle P, Evstifeeva T, Maisonneuve P, Macfarlane GJ, Pagano F Temporal trends in prostate cancer mortality: is the risk rising? J Urol (submitted)Google Scholar
- Cannon L, Bishop DT, Skolnick M, Hunt S, Lyon JL, Smart CR (1980) Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv 1:47–63Google Scholar
- Corder EH, Guess HA, Hulka B, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N (1993) Vitamin D and prostate cancer: a prediagnostic study with stored data. Cancer Epidemiol Biomark Prev 2:467–472Google Scholar
- Griffiths K, Turkes A, Harper MA (1990) Endocrine factors in the initiation, diagnosis and treatment of prostatic cancer. In: Voight K, Knabbe C (eds) Endocrine dependent tumours. Raven, New YorkGoogle Scholar
- International Agency for Research On Cancer (1986) Monographs on the evaluation of the carconogenic risk of chemicals to man, vol 38: tobacco smoking. IARC, LyonGoogle Scholar
- International Agency for Research on Cancer (1988) Monographs on the evaluation of carcinogenic risk to humans, vol 44: alcohol drinking. IARC, LyonGoogle Scholar
- International Agency for Research on Cancer (1991) Monographs on the evaluation of carcinogenic risk to humans, vol 51: coffee, tea, mate, methylxanthines (caffeine, theophylline, theobromine) and methylglyoxal. IARC, LyonGoogle Scholar
- Lancaster HO (1972) The mortality in Australia from cancer peculiar to the male. Med J Aust 2:41–44Google Scholar
- Schumann LM, Mandel J, Blackard C, Bauer H, Scarlett J and McHugh R (1977) Epidemiologic study of prostatic cancer: preliminary report. Cancer Treat Rep 61:181–186Google Scholar